Analysis of the BLINK study results showed a global more than localized impact on slowing eye growth in +2.50 CD multifocal contact lens wear. The slowed growth effects were greater centrally than peripherally. This suggests local defocus responses may not provide the full story behind myopia control mechanisms.
This cohort study from Australia reported a 14% incidence (onset) of myopia between ages 20 and 28, with almost 40% of myopes progressing by at least 0.50D. Axial length increase was also demonstrated. Risk factors were related to ethnicity, sex, sun exposure and parental myopia but not education level. This data advocates for active myopia management throughout the 20s.
Prediction modelling for future myopic progression was found to be more accurate when factors such as age, sex and ethnicity were considered, rather than prior progression. Myopia management should be initiated when myopia is apparent regardless of prior progression, rather than waiting to assess the progression rate.
The SCORM study analyzed the relationship between myopia progression a year after baseline and subsequent 2-year progression for myopic Singaporean children. Progression and age at baseline were found to be strongly associated with subsequent progression. However, they were shown to have limited predictive values and other factors are likely to determine future progression.
This study investigated the accuracy of using pre-treatment axial elongation and changes in refractive sphere in predicting myopia control success in orthokeratology. Axial length was the more accurate method for categorisation of slow, moderate or rapid progression, and fast progressors benefited the most from ortho-k wear.
The axial length growth trajectories modelled in this study revealed that regardless of a child’s age, a myopic shift of at least -0.85D and/or 0.74mm over three years suggests future myopia development. Read more about specific risk factors for younger children, and other ocular component findings in this large study of European children.